CIBC Private Wealth Group
KMTS

CIBC Private Wealth Group’s Kestra Medical Technologies KMTS Stock Holding History

CIBC Private Wealth Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$27 Hold
1
– – ﹤0.01% 3356
2025
Q3 		$24 Buy
+1
New +$18 ﹤0.01% 3041

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

CIBC Private Wealth Group's KMTS Position: Q4 2025 in Review

CIBC Private Wealth Group held its Kestra Medical Technologies (KMTS) position steady in Q4 2025 at 1 share worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #3356.

CIBC Private Wealth Group first reported a position in KMTS in Q3 2025 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold KMTS as of Q4 2025.

  • CIBC Private Wealth Group held 1 share of Kestra Medical Technologies worth $27 as of Q4 2025.
  • CIBC Private Wealth Group left its Kestra Medical Technologies share count unchanged in Q4 2025.
  • Kestra Medical Technologies made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3356 holding.
  • CIBC Private Wealth Group first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 2 quarters since.
  • 107 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.